Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function

Journal of Antibiotics

Volumn 70, Issue 2, 2017, Pages 152-157

  Szucs, Zsolt ^a   Csávás, Magdolna ^a   Roth, Erzsébet ^a   Borbás, Anikó ^a   Batta, Gyula ^b   Perret, Florent ^c   Ostorházi, Eszter ^d   Szatmári, Réka ^d   Vanderlinden, Evelien ^e   Naesens, Lieve ^e   Herczegh, Pál ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITÉ LYON 1   (France)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN DERIVATIVE; TEICOPLANIN PSEUDOAGLYCON DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; TEICOPLANIN;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CLICK CHEMISTRY; DRUG SCREENING; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; LIPOPHILICITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STRUCTURE ACTIVITY RELATION; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; SYNTHESIS;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; TEICOPLANIN; TRIAZOLES;

EID: 85010901161     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2016.80     Document Type: Article

References (28)

1. Binda, E., Marinelli, F., Marcone, G. L. Old, new glycopeptide antibiotics: action, resistance. Antibiotics 3, 572-594 (2014).
2. Van Bambeke, F., Lambert, D. M., Mingeot-Leclercq, M., Tulkens, P. M. in Infectious Diseases 2nd edn (eds Cohen, J., Powderly, W. G.) 1717-1720 (Mosby Publishing, London, UK, 2004).
3. Bager, F., Madsen, M., Christensen, J., Aarestrup, F. M. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry, pig farms. Prev. Vet. Med. 31, 95-112 (1997).
4. Levine, D. P. Vancomycin: a history. Clin. Infect. Dis. 42, S5-S12 (2006).
5. Trueba, F., Garrabe, E, Hadef, R., Fabre, R., Cavallo, J. High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study. J. Clin. Microbiol. 44, 1922-1923 (2006).
6. Sujatha, S., Praharaj, I. Glycopeptide resistance in Gram-positive cocci: a review. Interdiscip. Perspect. Infect. Dis. 2012, 781679 (2012).
7. Chen, A. Y., Zervos, M. J., Vazquez, J. A. Dalbavancin: a novel antimicrobial. Int. J. Clin. Pract. 61, 853-863 (2007).
8. Damodaran, S. E., Madhan, S. Telavancin: a novel lipoglycopeptide antibiotic. J. Pharmacol. Pharmacother. 2, 135-137 (2011).
9. Van Bambeke, F. Renaissance of antibiotics against difficult infections: focus on oritavancin, new ketolides, quinolones. Ann. Med. 46, 512-529 (2014).
10. Sztaricskai, F., et al. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. J. Antibiot. 59, 564-582 (2006).
11. Sipos, A., et al. Synthesis of isoindole, benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial, antiviral activities. Bioorg. Med. Chem. Lett. 22, 7092-7096 (2012).
12. Csávás, M., et al. Synthesis, antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl-, arylthiosubstituted maleimides. J. Antibiot. 68, 579-585 (2015).
13. Pintér, G., et al. A diazo transfer-click reaction route to new, lipophilic teicoplanin, ristocetin aglycon derivatives with high antibacterial, anti-influenza virus activity: an aggregation, receptor binding study. J. Med. Chem. 52, 6053-6061 (2009).
14. Norris, E. A., Thalia, I. N. Mechanism of action of oritavancin, related glycopeptide antibiotics. FEMS Microbiol. Rev. 26, 511-532 (2003).
15. Csávás, M., et al. Rapid synthesis of self-assembling 1, 2-thiomannobioside glycoconjugates as potential multivalent ligands of mannose-binding lectins. Tetrahedron Lett. 55, 6983-6986 (2014).
16. Sahoo, L., Singhamahapatra, A., Loganathan, D. Diversity oriented synthesis of novel haloglycolipids potentially useful for crystallization of integral membrane proteins. Org. Biomol. Chem. 12, 2615-2625 (2014).
17. Batool, T, et al. A convenient method for the synthesis of (prop-2-ynyloxy) benzene derivatives via reaction with propargyl bromide. PLoS ONE 9, e115457 (2014).
18. Casaschi, A., Grigg, R., Sansano, J. M. Palladium catalysed tandem cyclisation-anion capture. Part 6: Synthesis of sugar, nucleoside, purine, benzodiazepinone,-lactam analogues via capture of in situ generated vinylstannanes. Tetrahedron 56, 7553-7560 (2000).
19. Tanaka, S., Goi, T., Tanaka, K., Fukase, K. Highly efficient-sialylation by virtue of fixed dipole effects of N-phthalyl group: Application to continuous flow synthesis of (2-3),(2-6)-Neu5Ac-Gal motifs by microreactor. J. Carbohydr. Chem. 26, 369-394 (2007).
20. Bois, J., et al. Easy, selective method for the synthesis of various mono-Ofunctionalized calix[4]arenes: de-O-functionalization using TiCl4. J. Org. Chem. 75, 7550-7558 (2010).
21. Meldal, M., Tornøe, V. Cu-catalyzed azide-alkyne cycloaddition. Chem. Rev. 108, 2952-3015 (2008).
22. Clinical, Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. CLSI document M100-S22, Vol. 32, 1-184 (Clinical, Laboratory Standards Institute, Wayne, PA, 2012).
23. Gonzalez, N., et al. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum, soft tissue interstitial fluid concentrations reported in diabetic patients in a pharmacodynamic model. J. Antimicrob. Chemother. 68, 2291-2295 (2013).
24. Odenholt, I., Löwdin, E., Cars, O. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecium. Clin. Microbiol. Infect. 9, 930-970 (2003).
25. Chen, L., et al. Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Proc. Natl Acad. Sci. USA 100, 5658-5663 (2003).
26. Belley, A., et al. Oritavancin disrupts membrane integrity of Staphylococcus aureus, vancomycin-resistant enterococci to effect rapid bacterial killing. Antimicrob. Agents Chemother. 54, 5369-5371 (2010).
27. Allen, N. E., LeTourneau, D. L., Hobbs, J. N. The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics. J. Antibiot. 50, 677-684 (1997).
28. Vanderlinden, E., et al. Novel inhibitors of influenza virus fusion: structure-activity relationship, interaction with the viral hemagglutinin. J.Virol. 84, 4277-4288 (2010).